The growing landscape of solid tumor CAR T cell targets

The early clinical pipeline of CAR T cell therapies for solid tumors is growing, and it’s no longer concentrated around a small number of solid tumor-selective targets. 

According to BioCentury’s BCIQ database, there are CAR T cell candidates against at least 19 different targets in development for solid tumors. ...